Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- COE -10.7%, IMMY -7.9%, NKE -5.5%, PERY -3.2%, QIWI -0.9%, SCS -0.6%
Select financial related names showing weakness:
- ING -4.7% (media outlets run headlines tied to last week's annual report in which the company revealed that 'ING Bank is the subject of criminal investigations by Dutch authorities regarding various requirements related to the on-boarding of clients, money laundering and corrupt practices')
- LYG -1.7%, BCS -1.5%, RBS -1.5%, PUK -1.4%, CS -1.1%, BAC -0.9%, HSBC-0.7%, JPM -0.7%
Select oil/gas related names showing early weakness:
- SDRL -2.9%, RIG -1.3%, MRO -1.3%, APC -1.2%, STO -1.2%, CHK -0.7%, .
Other news:
- SHLD -17.6% (discloses in 10-K that its operating results indicate substantial doubt exists related to the Company's ability to continue as a going concern)
- IMMY -7.9% (entered into agreements with two accredited investors for a registered direct placement of 1,312,000 shares of common stock at a price of $2.40 per share), RGNX -6.1% (prices offering of 3.7 mln shares of common stock at $20.50 per share)
- ADAP -4% (Adaptimmune Therapeutics to offer and sell ADSs in underwritten public offering)
- DEA -2.4% (prices 4.3 mln common stock offering, all offered in connection with the forward sales agreements, at $19.00/share)
- WLL -1.9% (Moody's upgrades Whiting's CFR to B2, Positive Outlook)
- CALA -0.5% (offering of 6,830,000 shares of its common stock priced at $10.25/share)
Analyst comments:
- FTR -7.6% (downgraded to Sell from Neutral at Goldman)
- AAL -1.9% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- TDG -1.9% (downgraded to Market Perform from Outperform at Cowen)